top of page

Services

Nanomerics has the in-house capability to develop delivery and formulation technologies from chemistry and physical-chemistry to pharmacokinteic or phamacodynamic evaluation.

Formulation Feasability

Development and Evaluation

In vitro - In vivo

We offer a broad range of bioanalytical services

Scale-up

From mg to kg

Virpax.jpg

CSO Virpax Pharmaceuticals (USA)

“We partnered for 3 preclinical  development projects – from delivery to the brain for treatment of CNS conditions to antiviral indications.

From the initial consultation to the final stages of preclinical development, Nanomerics provided insightful guidance and innovative solutions to any project bottlenecks, which was crucial in advancing our assets. Their team demonstrated unparalleled expertise and dedication, generating high-quality preclinical data for patent filings and

IND application packages.

We can confidently link our programs progress and positive path to first-in-human studies to Nanomerics' exceptional leadership and R&D capabilities.”

N4-Pharma.png

Executive Director N4 Pharma (UK)

Our partnership with Nanomerics has played a critical role in advancing our asset in oncology. The Nanomerics team streamlined our gene delivery platform through preclinical development

- from formulation work and in vitro screening in cells to in vivo evaluation in animal models. They expertly navigated through roadblocks and necessary optimisations at each step. Their work has allowed us to take further steps towards commercialisation. 

We would recommend Nanomerics to any stakeholders in need of agile and competent R&D services to progress their assets through the preclinical development pipeline, especially in

oncology and gene delivery space.

bottom of page